In this Part 2 review of review atrial fibrillation, we covering direct current cardioversion (DCCV), bleeding and stroke risks, ablation, and left atrial appendage occlusion (LAAO). What are the situations in which CHA2DS2-VASc does not apply? Do you start anticoagulation on a patient who presents with a smartwatch-identified AF with no prior symptoms or diagnosis? How do you decide whether to refer a patient for percutaneous LAA occlusion? What are the success rates and complications of AF ablation? Tune in for answers to these questions.
Difficulty Level: Easy
You are listening to Hu Said: Cardiology Board Review Series (2024-2025 Season)
Please subscribe, rate, and support the channel! Ads help keep materials free for everyone.
More MedEd resources available at www.rueyhu.com
Updates at Twitter/X: @Ruey_Hu
